384 Oyster Point Boulevard
South San Francisco
70 articles with Fluxion Biosciences
Fluxion Launches IonFlux Mercury Ultra, the First Modular Ultra-Throughput Automated Patch Clamp System
Fluxion Biosciences, the global leader in automated patch clamp systems for ion channel drug discovery, just announced the launch of IonFlux Mercury Ultra, the system delivering the highest levels of throughput and modularity ever offered in a patch clamp platform.
Fluxion Launches BioFlux One, the Affordable System for Cellular Interaction Assays Under Physiological Flow
All the benefits of the industry leading BioFlux cell analysis platform, now in a configuration every lab can afford.
Fluxion Biosciences announces the launch of three new targeted NGS liquid biopsy panels: Spotlight Myeloid, Spotlight EGFR, and Spotlight TP53
Patented ERASE-Seq approach delivers ultra-high sensitivity somatic mutation detection using molecular amplification pools (MAPs) and background error correction
Grant will support development of Spotlight™ NIPT, a novel single-cell NGS assay for non-invasive fetal testing using the mother's blood sample
Inter-sample digital processing improves sensitivity and specificity of variant calling; results superior to molecular barcoding approaches
Fluxion Biosciences announced today that its ERASE-Seq bioinformatics solution can now be utilized for variant calling from a wide range of targeted cancer panels.
The new plates are available immediately.
Fluxion Biosciences Appoints Genetracer Biotech Of Spain As An Isoflux Liquid Biopsy Certified Service Provider
Fluxion Biosciences Announces The Launch Of IonFlux Mercury, Its Next Generation Automated Patch Clamp System. The System Will Be Sold Directly By Fluxion Biosciences
Fluxion Biosciences Announces Liquid Biopsy Collaboration With University of Texas Health Science Center
Fluxion Biosciences Announced The Use Of Its IonFlux Automated Patch Clamp System In The Discovery Of Genentech GNE-0723, A Novel Drug Compound Suitable For In Vivo Characterization
Fluxion Biosciences Launches New Range Of Circulating Tumor Cell (CTC) Recovery Kits- First Launch Of Commercial Kits Targeting EMT Cells
Fluxion Biosciences And Swift Biosciences Announce Jointly Developed Next-Generation Sequencing Workflow For Somatic Mutation Detection From Liquid Biopsy Samples
Fluxion Biosciences Introduces The Isoflux EMT Enrichment Kit For More Comprehensive Circulating Tumor Cell Analysis
Fluxion Biosciences Announces Collaboration With Stanford University School of Medicine For New Circulating Cancer Biomarkers